Regarding products purchased outside of “normal pharmaceutical distribution channels”

Return Solutions, Inc. (RSI) shall not be liable for the value of, and cannot guarantee credit for products that were purchased outside of “normal pharmaceutical distribution channels”.

This includes products that were not purchased directly by our Customer from a particular manufacturer or directly by our Customer from an approved wholesaler/distributor of said manufacturer.  This also includes products that were purchased outside of the United States, counterfeit items, and any product purchased by Customer on a non-returnable basis, including short-dated product purchased at a discounted price.

Please note that manufacturers may require proof-of-purchase, and reserve the right to destroy such product without issuing credit.

If such product has been shipped by RSI or its Customer to a manufacturer or their agent, RSI cannot guarantee the return of product to Customer, and in no way shall RSI be responsible for reimbursing Customer for said product.  In the event product is available for return to Customer, it shall be at Customer’s expense.

In any dispute, RSI has the right to require Customer to produce an invoice showing purchase of disputed items.   Failure by Customer to provide such an invoice shall release RSI from any and all liability of products involved in dispute.  In no instance shall RSI’s liability for any product exceed the actual cost paid for product by Customer.

If Customer is unable to provide a purchase history that does not meet our Pedigree Policy, or product does not meet our guidelines, product must be returned to Customer at its expense.  If Customer is unable to have product returned to it at Customer’s expense within 30 days, product is subject to be destroyed without any payments or credit issued to Customer.

More information on drug pedigrees is available on the FDA website at: Pedigree Requirements under 21 CFR Part 203